Bacteria can be made to spin spider silk

Biological and medical research is on the threshold of a new era based on better understanding of how large organic molecules bind together and recognise each other. There is great potential for exploiting the molecular docking processes that are commonplace in all organisms to develop new drugs that act more specifically without adverse side effects, and construct novel materials by mimicking nature.

A recent workshop on Biosupramolecular Chemistry organised by the European Science Foundation (ESF) strengthened Europe’s platform for progress towards these goals by bringing together scientists in the relevant fields and identifying key research targets. The workshop also identified some applications close to fruition, including the engineering of bacteria to produce silks as strong for their thickness as spider webs.

It has been a longstanding challenge to emulate the mechanical properties of spider silk, which combines stiffness and tensile strength with the ability to become elastic under high strains to protect against destruction. A recent project led by Thomas Scheibel at the Technical University of Munich is close to a solution that could have a host of practical applications ranging from biodegradable fishing line to body armour.

The artificial spider silk production exemplified the expertise and skills required for successful applications in biosupramolecular chemistry, in this case by combining genetic engineering with sophisticated micro-manipulation techniques to optimise production of the desired material. Firstly genes were inserted into the bacteria to produce proteins as similar as possible to spider silk. Then microfluidic approaches, dealing with fluids at very small scales, were used to fabricate the silk. Finally the mechanical properties were optimised further by substituting some of the amino acid components of the proteins.

Other applications of biosupramolecular chemistry are further off, but coming into range, according to the ESF workshop convenor, Professor Anthony Davis from Bristol University in the UK. But the most important aspect of the ESF workshop was the bringing together of scientists in two previously distinct fields, said Davis. “Our main aim was to get two groups of scientists talking to each other - the supramolecular chemists, and a group of biologists who might be termed ‘biomolecular engineers’,” said Davis. “Certainly this objective was fulfilled.” Supramolecular chemists study and manipulate the interactions between molecules in general, while biomolecular engineers specialise in exploiting the large organic molecules found in Nature.

Biological macromolecules include proteins comprising amino acids, complex carbohydrates made from simpler sugar molecules, as well as both RNA and DNA made from nucleic acids. Unlike small molecules, these large constructions exhibit multiple chemical properties at different parts of their surface, which means that interactions between them depend on geometrical features. It is the geometrical arrangement of the component parts, as much as their chemical identity, that determines how a macromolecule will behave and interact with other molecules both large and small. Some molecules will only react or bind with certain others, often temporarily, on a “lock and key” basis determined by the relative shapes of the surface. Such transient associations between large molecules (supramolecules) are very important in biology, for example in the binding between antibodies and antigens in the immune response, and also between an enzyme and its substrate, i.e. the compound it is acting upon.

These looser interactions between large molecules are called non-covalent because they do not involve sharing of electrons, but instead exploit variations in electrical charge distribution in their vicinity. Since each individual bond is weak, non-covalent bonding relies on the collective strength of multiple bonds and is therefore only a viable mechanism for joining larger molecules together.

As well as being important for temporary binding, non-covalent bonding forces are also essential for maintaining the structure of large proteins, and for the DNA double helix, on a longer term basis, by holding the components together. This is a very complex subject given the huge number of combinations of components involved, and so a significant advance reported at the ESF Biosupramolecular conference by Andrei Lupas from the Max Planck Institute for Developmental Biology in Germany was of a dictionary representing proteins by motifs, that is smaller coherent arrangements of its constituent amino acids, derived from studying their evolutionary history. Lupas showed how such a dictionary could be used to derive evolutionary relationships between proteins. This could have great application in evolutionary biology and also for determining the role of proteins whose function is as yet largely unknown, as well as understanding diseases where protein interactions go wrong.

Having identified many promising avenues of research, the ESF workshop is likely to be followed up by further meetings, according to Davis.”We hope to organise another meeting in 2009, and maybe keep going to create a regular series of symposia.”

Source: European Science Foundation

Related stories:

Future for clean energy lies in 'big bang' of evolution
Amid mounting agreement that future clean, "carbon-neutral", energy will rely on efficient conversion of the sun's light energy into fuels and electric power, attention is focusing on one of the most ancient groups of organism, the cyanobacteria. Dramatic progress has been made over the last decade understanding the fundamental reaction of photosynthesis that evolved in cyanobacteria 3.7 billion years ago, which for the first time used water molecules as a source of electrons to transport energy derived from sunlight, while converting carbon dioxide into oxygen. The light harvesting systems gave the bacteria their blue ("cyano") colour, and paved the way for plants to evolve by "kidnapping" bacteria to provide their photosynthetic engines, and for animals by liberating oxygen for them to breathe, by splitting water molecules. For humans now there is the tantalising possibility of tweaking the photosynthetic reactions of cyanobacteria to produce fuels we want such as hydrogen, alcohols or even hydrocarbons, rather than carbohydrates.
RNA emerges from DNA's shadow
RNA, the transporter of genetic information within the cell, has emerged from the shadow of DNA to become one of the hottest research areas of molecular biology, with implications for many diseases as well as understanding of evolution. But the field is complex, requiring access to the latest equipment and techniques of imaging, gene expression analysis and bioinformatics, as well as cross-pollination between multiple scientific disciplines. This has led to a major European push to bring the field together via a network of overlapping multidisciplinary projects, spearheaded by the European Science Foundation (ESF) with its EUROCORES Programme RNAQuality.
New treatments for viral and other diseases by blocking genes
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
RNA molecules boost vaccine effectiveness
(PhysOrg.com) -- A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.
Protection for stressed-out bacteria identified
An international team of researchers is a step closer to understanding the spread of deadly diseases such as listeriosis, after observing for the first time how bacteria respond to stress.
New research may help to design better gene therapy vectors
(PhysOrg.com) -- Research published by scientists from the University of Reading may offer an insight into ways of making safer and more specific gene therapy vectors. The research, published in the journal Nature Structural and Molecular Biology, describes the structure of the viral fusion protein gp64, which is involved in the mechanism which viruses use to invade host cells. In the past, Bacloviruses have been suggested as possible gene therapy vectors due to the way in which they enter host cells, but there has been little evidence which explain these properties up to now.
Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
An atomic-resolution view of an enzyme found only in the eye has given researchers at the University of Washington (UW) clues about how this enzyme, essential to vision, is activated. The enzyme, phosphodiesterase 6 (PDE6), is central to the way light entering the retina is converted into a cascade of signals to the brain.

News discussion:

General Science news